Cargando…

Quantitative analysis on the characteristics of targets with FDA approved drugs

Accumulated knowledge of genomic information, systems biology, and disease mechanisms provide an unprecedented opportunity to elucidate the genetic basis of diseases, and to discover new and novel therapeutic targets from the wealth of genomic data. With hundreds to a few thousand potential targets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakharkar, Meena K., Li, Peng, Zhong, Zhaowei, Sakharkar, Kishore R.
Formato:	Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2007
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2140153/ https://www.ncbi.nlm.nih.gov/pubmed/18167532

Ejemplares similares

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa
por: Tin, San, et al.
Publicado: (2009)

Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses
por: Sakharkar, Meena K, et al.
Publicado: (2009)

Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro
por: Jayaraman, Premkumar, et al.
Publicado: (2010)

A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species
por: Perumal, Deepak, et al.
Publicado: (2008)

Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer
por: Sakharkar, Meena K., et al.
Publicado: (2013)

T-Epitope Designer: A HLA-peptide binding prediction server
por: Kangueane, Pandjassarame, et al.
Publicado: (2005)

Genome SEGE: A database for 'intronless' genes in eukaryotic genomes
por: Sakharkar, Meena Kishore, et al.
Publicado: (2004)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer
por: Yang, Bonnie Yang, et al.
Publicado: (2022)

Enhancing Drug Efficacy against Mastitis Pathogens—An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis
por: Rajamanickam, Karthic, et al.
Publicado: (2020)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

A Comparative Study of Metabolic Network Topology between a Pathogenic and a Non-Pathogenic Bacterium for Potential Drug Target Identification
por: Perumal, Deepak, et al.
Publicado: (2009)

Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
por: Jayaraman, Premkumar, et al.
Publicado: (2013)

Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer
por: Shashni, Babita, et al.
Publicado: (2013)

Retraction Note to: Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer
por: Shashni, Babita, et al.
Publicado: (2022)

Gallic Acid Potentiates the Antimicrobial Activity of Tulathromycin Against Two Key Bovine Respiratory Disease (BRD) Causing-Pathogens
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

Phytochemicals as alternatives to antibiotics against major pathogens involved in bovine respiratory disease(BRD)and bovine mastitis(BM)
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

A Novel Antimicrobial–Phytochemical Conjugate With Antimicrobial Activity Against Streptococcus uberis, Enterococcus faecium, and Enterococcus faecalis
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

Identification of novel drug targets in bovine respiratory disease: an essential step in applying biotechnologic techniques to develop more effective therapeutic treatments
por: Sakharkar, Meena Kishore, et al.
Publicado: (2018)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Pairwise correlation of genes involved in glucose metabolism: a potential diagnostic marker of cancer?
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

Identification of FDA-approved drugs targeting the Farnesoid X Receptor
por: van de Wiel, Sandra M. W., et al.
Publicado: (2019)

Insight into gene fusion from molecular dynamics simulation of fused and un-fused IGPS (Imidazole Glycerol Phosphate Synthetase)
por: Yiting, Yu, et al.
Publicado: (2006)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

Identification of natural products and FDA-approved drugs for targeting cancer stem cell (CSC) propagation
por: Bonuccelli, Gloria, et al.
Publicado: (2022)

Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells
por: Ling, Binbing, et al.
Publicado: (2016)

Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes
por: Wu, Xiyuan, et al.
Publicado: (2020)

Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells
por: Wu, Xiyuan, et al.
Publicado: (2023)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
por: Hou, Zhi-Jie, et al.
Publicado: (2015)

Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
por: Cicenas, Jonas, et al.
Publicado: (2021)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
por: Nishikawa, Shigeto, et al.
Publicado: (2023)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

Potential of lipoproteins as biomarkers in acute myocardial infarction
por: Khan, Haseeb Ahmad, et al.
Publicado: (2017)

Screening of antibacterial compounds with novel structure from the FDA approved drugs using machine learning methods
por: Li, Wen-Xing, et al.
Publicado: (2022)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0ja0k7fdqf6v8kmmt4odhunkan